Patients with ophiasis may be categorized into 3 distinct subtypes that can guide early intervention and stratify treatment.
Promising early results regarding the use of litifilimab in patients with CLE were presented as part of a late-breaking session at the 2026 AAD Annual Meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results